ZymoGenetics, Inc. Gets $79 Million in Stock Sale
Xconomy.com -- ZymoGenetics, the Seattle-based biotech company, said today it has raised about $79 million after expenses from an underwritten stock offering. The company sold 14 million shares at $6 apiece, and also offered its underwriters a 30-day option to buy another 2.1 million shares.